All patients with pathognomonic aggregation abnormalities (e.g., from BSS, type 2B VWD, and suspected ITGA2/ITGB3‐RT) had consistent, abnormal findings, as did patients with FPDMM and PFD secondary to underlying hematological disorders and some other disorders (details in Table 5 footnote). This evidence concerns the gene ITGA2 and hematologic disorder.